Medical Devices & Consumables
Global Drug-Device Combination Products Market Research Report 2026
- May 01, 26
- ID: 757822
- Pages: 149
- Figures: 160
- Views: 9
This report delivers a comprehensive overview of the global Drug-Device Combination Products market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Drug-Device Combination Products. The Drug-Device Combination Products market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Drug-Device Combination Products market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Drug-Device Combination Products manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
GSK
Novo Nordisk
Eli Lilly
AstraZeneca
Sanofi
Boston Scientific
Abbott
Boehringer Ingelheim
Medtronic
Viatris
3M
Hisamitsu
Smith & Nephew
Molnlycke
Teleflex
BD
Lepu Medical
MicroPort
Terumo
B. Braun
Antares Pharma
Segment by Type
Drug-Coated Device
Prefilled Drug Delivery Systems
Nebulizer and Inhaler
Transdermal Delivery System
Others
Segment by Application
Hospital andClinic
Retail Pharmacies
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Drug-Device Combination Products companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
The report segments the global Drug-Device Combination Products market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Drug-Device Combination Products manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
GSK
Novo Nordisk
Eli Lilly
AstraZeneca
Sanofi
Boston Scientific
Abbott
Boehringer Ingelheim
Medtronic
Viatris
3M
Hisamitsu
Smith & Nephew
Molnlycke
Teleflex
BD
Lepu Medical
MicroPort
Terumo
B. Braun
Antares Pharma
Segment by Type
Drug-Coated Device
Prefilled Drug Delivery Systems
Nebulizer and Inhaler
Transdermal Delivery System
Others
Segment by Application
Hospital andClinic
Retail Pharmacies
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Drug-Device Combination Products companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug-Device Combination Products Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Drug-Coated Device
1.2.3 Prefilled Drug Delivery Systems
1.2.4 Nebulizer and Inhaler
1.2.5 Transdermal Delivery System
1.2.6 Others
1.3 Market by Application
1.3.1 Global Drug-Device Combination Products Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital andClinic
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug-Device Combination Products Market Perspective (2021–2032)
2.2 Global Drug-Device Combination Products Growth Trends by Region
2.2.1 Global Drug-Device Combination Products Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Drug-Device Combination Products Historic Market Size by Region (2021–2026)
2.2.3 Drug-Device Combination Products Forecasted Market Size by Region (2027–2032)
2.3 Drug-Device Combination Products Market Dynamics
2.3.1 Drug-Device Combination Products Industry Trends
2.3.2 Drug-Device Combination Products Market Drivers
2.3.3 Drug-Device Combination Products Market Challenges
2.3.4 Drug-Device Combination Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug-Device Combination Products Players by Revenue
3.1.1 Global Top Drug-Device Combination Products Players by Revenue (2021–2026)
3.1.2 Global Drug-Device Combination Products Revenue Market Share by Players (2021–2026)
3.2 Global Top Drug-Device Combination Products Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Drug-Device Combination Products Revenue
3.4 Global Drug-Device Combination Products Market Concentration Ratio
3.4.1 Global Drug-Device Combination Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug-Device Combination Products Revenue in 2025
3.5 Global Key Players of Drug-Device Combination Products Head Offices and Areas Served
3.6 Global Key Players of Drug-Device Combination Products, Products and Applications
3.7 Global Key Players of Drug-Device Combination Products, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Drug-Device Combination Products Breakdown Data by Type
4.1 Global Drug-Device Combination Products Historic Market Size by Type (2021–2026)
4.2 Global Drug-Device Combination Products Forecasted Market Size by Type (2027–2032)
5 Drug-Device Combination Products Breakdown Data by Application
5.1 Global Drug-Device Combination Products Historic Market Size by Application (2021–2026)
5.2 Global Drug-Device Combination Products Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Drug-Device Combination Products Market Size (2021–2032)
6.2 North America Drug-Device Combination Products Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Drug-Device Combination Products Market Size by Country (2021–2026)
6.4 North America Drug-Device Combination Products Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug-Device Combination Products Market Size (2021–2032)
7.2 Europe Drug-Device Combination Products Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Drug-Device Combination Products Market Size by Country (2021–2026)
7.4 Europe Drug-Device Combination Products Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Drug-Device Combination Products Market Size (2021–2032)
8.2 Asia-Pacific Drug-Device Combination Products Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Drug-Device Combination Products Market Size by Region (2021–2026)
8.4 Asia-Pacific Drug-Device Combination Products Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Drug-Device Combination Products Market Size (2021–2032)
9.2 Latin America Drug-Device Combination Products Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Drug-Device Combination Products Market Size by Country (2021–2026)
9.4 Latin America Drug-Device Combination Products Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug-Device Combination Products Market Size (2021–2032)
10.2 Middle East & Africa Drug-Device Combination Products Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Drug-Device Combination Products Market Size by Country (2021–2026)
10.4 Middle East & Africa Drug-Device Combination Products Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Drug-Device Combination Products Introduction
11.1.4 GSK Revenue in Drug-Device Combination Products Business (2021–2026)
11.1.5 GSK Recent Development
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Details
11.2.2 Novo Nordisk Business Overview
11.2.3 Novo Nordisk Drug-Device Combination Products Introduction
11.2.4 Novo Nordisk Revenue in Drug-Device Combination Products Business (2021–2026)
11.2.5 Novo Nordisk Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Drug-Device Combination Products Introduction
11.3.4 Eli Lilly Revenue in Drug-Device Combination Products Business (2021–2026)
11.3.5 Eli Lilly Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Drug-Device Combination Products Introduction
11.4.4 AstraZeneca Revenue in Drug-Device Combination Products Business (2021–2026)
11.4.5 AstraZeneca Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Drug-Device Combination Products Introduction
11.5.4 Sanofi Revenue in Drug-Device Combination Products Business (2021–2026)
11.5.5 Sanofi Recent Development
11.6 Boston Scientific
11.6.1 Boston Scientific Company Details
11.6.2 Boston Scientific Business Overview
11.6.3 Boston Scientific Drug-Device Combination Products Introduction
11.6.4 Boston Scientific Revenue in Drug-Device Combination Products Business (2021–2026)
11.6.5 Boston Scientific Recent Development
11.7 Abbott
11.7.1 Abbott Company Details
11.7.2 Abbott Business Overview
11.7.3 Abbott Drug-Device Combination Products Introduction
11.7.4 Abbott Revenue in Drug-Device Combination Products Business (2021–2026)
11.7.5 Abbott Recent Development
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Details
11.8.2 Boehringer Ingelheim Business Overview
11.8.3 Boehringer Ingelheim Drug-Device Combination Products Introduction
11.8.4 Boehringer Ingelheim Revenue in Drug-Device Combination Products Business (2021–2026)
11.8.5 Boehringer Ingelheim Recent Development
11.9 Medtronic
11.9.1 Medtronic Company Details
11.9.2 Medtronic Business Overview
11.9.3 Medtronic Drug-Device Combination Products Introduction
11.9.4 Medtronic Revenue in Drug-Device Combination Products Business (2021–2026)
11.9.5 Medtronic Recent Development
11.10 Viatris
11.10.1 Viatris Company Details
11.10.2 Viatris Business Overview
11.10.3 Viatris Drug-Device Combination Products Introduction
11.10.4 Viatris Revenue in Drug-Device Combination Products Business (2021–2026)
11.10.5 Viatris Recent Development
11.11 3M
11.11.1 3M Company Details
11.11.2 3M Business Overview
11.11.3 3M Drug-Device Combination Products Introduction
11.11.4 3M Revenue in Drug-Device Combination Products Business (2021–2026)
11.11.5 3M Recent Development
11.12 Hisamitsu
11.12.1 Hisamitsu Company Details
11.12.2 Hisamitsu Business Overview
11.12.3 Hisamitsu Drug-Device Combination Products Introduction
11.12.4 Hisamitsu Revenue in Drug-Device Combination Products Business (2021–2026)
11.12.5 Hisamitsu Recent Development
11.13 Smith & Nephew
11.13.1 Smith & Nephew Company Details
11.13.2 Smith & Nephew Business Overview
11.13.3 Smith & Nephew Drug-Device Combination Products Introduction
11.13.4 Smith & Nephew Revenue in Drug-Device Combination Products Business (2021–2026)
11.13.5 Smith & Nephew Recent Development
11.14 Molnlycke
11.14.1 Molnlycke Company Details
11.14.2 Molnlycke Business Overview
11.14.3 Molnlycke Drug-Device Combination Products Introduction
11.14.4 Molnlycke Revenue in Drug-Device Combination Products Business (2021–2026)
11.14.5 Molnlycke Recent Development
11.15 Teleflex
11.15.1 Teleflex Company Details
11.15.2 Teleflex Business Overview
11.15.3 Teleflex Drug-Device Combination Products Introduction
11.15.4 Teleflex Revenue in Drug-Device Combination Products Business (2021–2026)
11.15.5 Teleflex Recent Development
11.16 BD
11.16.1 BD Company Details
11.16.2 BD Business Overview
11.16.3 BD Drug-Device Combination Products Introduction
11.16.4 BD Revenue in Drug-Device Combination Products Business (2021–2026)
11.16.5 BD Recent Development
11.17 Lepu Medical
11.17.1 Lepu Medical Company Details
11.17.2 Lepu Medical Business Overview
11.17.3 Lepu Medical Drug-Device Combination Products Introduction
11.17.4 Lepu Medical Revenue in Drug-Device Combination Products Business (2021–2026)
11.17.5 Lepu Medical Recent Development
11.18 MicroPort
11.18.1 MicroPort Company Details
11.18.2 MicroPort Business Overview
11.18.3 MicroPort Drug-Device Combination Products Introduction
11.18.4 MicroPort Revenue in Drug-Device Combination Products Business (2021–2026)
11.18.5 MicroPort Recent Development
11.19 Terumo
11.19.1 Terumo Company Details
11.19.2 Terumo Business Overview
11.19.3 Terumo Drug-Device Combination Products Introduction
11.19.4 Terumo Revenue in Drug-Device Combination Products Business (2021–2026)
11.19.5 Terumo Recent Development
11.20 B. Braun
11.20.1 B. Braun Company Details
11.20.2 B. Braun Business Overview
11.20.3 B. Braun Drug-Device Combination Products Introduction
11.20.4 B. Braun Revenue in Drug-Device Combination Products Business (2021–2026)
11.20.5 B. Braun Recent Development
11.21 Antares Pharma
11.21.1 Antares Pharma Company Details
11.21.2 Antares Pharma Business Overview
11.21.3 Antares Pharma Drug-Device Combination Products Introduction
11.21.4 Antares Pharma Revenue in Drug-Device Combination Products Business (2021–2026)
11.21.5 Antares Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug-Device Combination Products Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Drug-Coated Device
1.2.3 Prefilled Drug Delivery Systems
1.2.4 Nebulizer and Inhaler
1.2.5 Transdermal Delivery System
1.2.6 Others
1.3 Market by Application
1.3.1 Global Drug-Device Combination Products Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital andClinic
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug-Device Combination Products Market Perspective (2021–2032)
2.2 Global Drug-Device Combination Products Growth Trends by Region
2.2.1 Global Drug-Device Combination Products Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Drug-Device Combination Products Historic Market Size by Region (2021–2026)
2.2.3 Drug-Device Combination Products Forecasted Market Size by Region (2027–2032)
2.3 Drug-Device Combination Products Market Dynamics
2.3.1 Drug-Device Combination Products Industry Trends
2.3.2 Drug-Device Combination Products Market Drivers
2.3.3 Drug-Device Combination Products Market Challenges
2.3.4 Drug-Device Combination Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug-Device Combination Products Players by Revenue
3.1.1 Global Top Drug-Device Combination Products Players by Revenue (2021–2026)
3.1.2 Global Drug-Device Combination Products Revenue Market Share by Players (2021–2026)
3.2 Global Top Drug-Device Combination Products Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Drug-Device Combination Products Revenue
3.4 Global Drug-Device Combination Products Market Concentration Ratio
3.4.1 Global Drug-Device Combination Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug-Device Combination Products Revenue in 2025
3.5 Global Key Players of Drug-Device Combination Products Head Offices and Areas Served
3.6 Global Key Players of Drug-Device Combination Products, Products and Applications
3.7 Global Key Players of Drug-Device Combination Products, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Drug-Device Combination Products Breakdown Data by Type
4.1 Global Drug-Device Combination Products Historic Market Size by Type (2021–2026)
4.2 Global Drug-Device Combination Products Forecasted Market Size by Type (2027–2032)
5 Drug-Device Combination Products Breakdown Data by Application
5.1 Global Drug-Device Combination Products Historic Market Size by Application (2021–2026)
5.2 Global Drug-Device Combination Products Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Drug-Device Combination Products Market Size (2021–2032)
6.2 North America Drug-Device Combination Products Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Drug-Device Combination Products Market Size by Country (2021–2026)
6.4 North America Drug-Device Combination Products Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug-Device Combination Products Market Size (2021–2032)
7.2 Europe Drug-Device Combination Products Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Drug-Device Combination Products Market Size by Country (2021–2026)
7.4 Europe Drug-Device Combination Products Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Drug-Device Combination Products Market Size (2021–2032)
8.2 Asia-Pacific Drug-Device Combination Products Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Drug-Device Combination Products Market Size by Region (2021–2026)
8.4 Asia-Pacific Drug-Device Combination Products Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Drug-Device Combination Products Market Size (2021–2032)
9.2 Latin America Drug-Device Combination Products Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Drug-Device Combination Products Market Size by Country (2021–2026)
9.4 Latin America Drug-Device Combination Products Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug-Device Combination Products Market Size (2021–2032)
10.2 Middle East & Africa Drug-Device Combination Products Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Drug-Device Combination Products Market Size by Country (2021–2026)
10.4 Middle East & Africa Drug-Device Combination Products Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Drug-Device Combination Products Introduction
11.1.4 GSK Revenue in Drug-Device Combination Products Business (2021–2026)
11.1.5 GSK Recent Development
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Details
11.2.2 Novo Nordisk Business Overview
11.2.3 Novo Nordisk Drug-Device Combination Products Introduction
11.2.4 Novo Nordisk Revenue in Drug-Device Combination Products Business (2021–2026)
11.2.5 Novo Nordisk Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Drug-Device Combination Products Introduction
11.3.4 Eli Lilly Revenue in Drug-Device Combination Products Business (2021–2026)
11.3.5 Eli Lilly Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Drug-Device Combination Products Introduction
11.4.4 AstraZeneca Revenue in Drug-Device Combination Products Business (2021–2026)
11.4.5 AstraZeneca Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Drug-Device Combination Products Introduction
11.5.4 Sanofi Revenue in Drug-Device Combination Products Business (2021–2026)
11.5.5 Sanofi Recent Development
11.6 Boston Scientific
11.6.1 Boston Scientific Company Details
11.6.2 Boston Scientific Business Overview
11.6.3 Boston Scientific Drug-Device Combination Products Introduction
11.6.4 Boston Scientific Revenue in Drug-Device Combination Products Business (2021–2026)
11.6.5 Boston Scientific Recent Development
11.7 Abbott
11.7.1 Abbott Company Details
11.7.2 Abbott Business Overview
11.7.3 Abbott Drug-Device Combination Products Introduction
11.7.4 Abbott Revenue in Drug-Device Combination Products Business (2021–2026)
11.7.5 Abbott Recent Development
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Details
11.8.2 Boehringer Ingelheim Business Overview
11.8.3 Boehringer Ingelheim Drug-Device Combination Products Introduction
11.8.4 Boehringer Ingelheim Revenue in Drug-Device Combination Products Business (2021–2026)
11.8.5 Boehringer Ingelheim Recent Development
11.9 Medtronic
11.9.1 Medtronic Company Details
11.9.2 Medtronic Business Overview
11.9.3 Medtronic Drug-Device Combination Products Introduction
11.9.4 Medtronic Revenue in Drug-Device Combination Products Business (2021–2026)
11.9.5 Medtronic Recent Development
11.10 Viatris
11.10.1 Viatris Company Details
11.10.2 Viatris Business Overview
11.10.3 Viatris Drug-Device Combination Products Introduction
11.10.4 Viatris Revenue in Drug-Device Combination Products Business (2021–2026)
11.10.5 Viatris Recent Development
11.11 3M
11.11.1 3M Company Details
11.11.2 3M Business Overview
11.11.3 3M Drug-Device Combination Products Introduction
11.11.4 3M Revenue in Drug-Device Combination Products Business (2021–2026)
11.11.5 3M Recent Development
11.12 Hisamitsu
11.12.1 Hisamitsu Company Details
11.12.2 Hisamitsu Business Overview
11.12.3 Hisamitsu Drug-Device Combination Products Introduction
11.12.4 Hisamitsu Revenue in Drug-Device Combination Products Business (2021–2026)
11.12.5 Hisamitsu Recent Development
11.13 Smith & Nephew
11.13.1 Smith & Nephew Company Details
11.13.2 Smith & Nephew Business Overview
11.13.3 Smith & Nephew Drug-Device Combination Products Introduction
11.13.4 Smith & Nephew Revenue in Drug-Device Combination Products Business (2021–2026)
11.13.5 Smith & Nephew Recent Development
11.14 Molnlycke
11.14.1 Molnlycke Company Details
11.14.2 Molnlycke Business Overview
11.14.3 Molnlycke Drug-Device Combination Products Introduction
11.14.4 Molnlycke Revenue in Drug-Device Combination Products Business (2021–2026)
11.14.5 Molnlycke Recent Development
11.15 Teleflex
11.15.1 Teleflex Company Details
11.15.2 Teleflex Business Overview
11.15.3 Teleflex Drug-Device Combination Products Introduction
11.15.4 Teleflex Revenue in Drug-Device Combination Products Business (2021–2026)
11.15.5 Teleflex Recent Development
11.16 BD
11.16.1 BD Company Details
11.16.2 BD Business Overview
11.16.3 BD Drug-Device Combination Products Introduction
11.16.4 BD Revenue in Drug-Device Combination Products Business (2021–2026)
11.16.5 BD Recent Development
11.17 Lepu Medical
11.17.1 Lepu Medical Company Details
11.17.2 Lepu Medical Business Overview
11.17.3 Lepu Medical Drug-Device Combination Products Introduction
11.17.4 Lepu Medical Revenue in Drug-Device Combination Products Business (2021–2026)
11.17.5 Lepu Medical Recent Development
11.18 MicroPort
11.18.1 MicroPort Company Details
11.18.2 MicroPort Business Overview
11.18.3 MicroPort Drug-Device Combination Products Introduction
11.18.4 MicroPort Revenue in Drug-Device Combination Products Business (2021–2026)
11.18.5 MicroPort Recent Development
11.19 Terumo
11.19.1 Terumo Company Details
11.19.2 Terumo Business Overview
11.19.3 Terumo Drug-Device Combination Products Introduction
11.19.4 Terumo Revenue in Drug-Device Combination Products Business (2021–2026)
11.19.5 Terumo Recent Development
11.20 B. Braun
11.20.1 B. Braun Company Details
11.20.2 B. Braun Business Overview
11.20.3 B. Braun Drug-Device Combination Products Introduction
11.20.4 B. Braun Revenue in Drug-Device Combination Products Business (2021–2026)
11.20.5 B. Braun Recent Development
11.21 Antares Pharma
11.21.1 Antares Pharma Company Details
11.21.2 Antares Pharma Business Overview
11.21.3 Antares Pharma Drug-Device Combination Products Introduction
11.21.4 Antares Pharma Revenue in Drug-Device Combination Products Business (2021–2026)
11.21.5 Antares Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Drug-Device Combination Products Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Drug-Coated Device
Table 3. Key Players of Prefilled Drug Delivery Systems
Table 4. Key Players of Nebulizer and Inhaler
Table 5. Key Players of Transdermal Delivery System
Table 6. Key Players of Others
Table 7. Global Drug-Device Combination Products Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Drug-Device Combination Products Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 9. Global Drug-Device Combination Products Market Size by Region (US$ Million), 2021–2026
Table 10. Global Drug-Device Combination Products Market Share by Region (2021–2026)
Table 11. Global Drug-Device Combination Products Forecasted Market Size by Region (US$ Million), 2027–2032
Table 12. Global Drug-Device Combination Products Market Share by Region (2027–2032)
Table 13. Drug-Device Combination Products Market Trends
Table 14. Drug-Device Combination Products Market Drivers
Table 15. Drug-Device Combination Products Market Challenges
Table 16. Drug-Device Combination Products Market Restraints
Table 17. Global Drug-Device Combination Products Revenue by Players (US$ Million), 2021–2026
Table 18. Global Drug-Device Combination Products Market Share by Players (2021–2026)
Table 19. Global Top Drug-Device Combination Products Players by Tier (Tier 1, Tier 2, and Tier 3), based on Drug-Device Combination Products Revenue, 2025
Table 20. Ranking of Global Top Drug-Device Combination Products Companies by Revenue (US$ Million) in 2025
Table 21. Global 5 Largest Players Market Share by Drug-Device Combination Products Revenue (CR5 and HHI), 2021–2026
Table 22. Global Key Players of Drug-Device Combination Products, Headquarters and Area Served
Table 23. Global Key Players of Drug-Device Combination Products, Products and Applications
Table 24. Global Key Players of Drug-Device Combination Products, Date of General Availability (GA)
Table 25. Mergers and Acquisitions, Expansion Plans
Table 26. Global Drug-Device Combination Products Market Size by Type (US$ Million), 2021–2026
Table 27. Global Drug-Device Combination Products Revenue Market Share by Type (2021–2026)
Table 28. Global Drug-Device Combination Products Forecasted Market Size by Type (US$ Million), 2027–2032
Table 29. Global Drug-Device Combination Products Revenue Market Share by Type (2027–2032)
Table 30. Global Drug-Device Combination Products Market Size by Application (US$ Million), 2021–2026
Table 31. Global Drug-Device Combination Products Revenue Market Share by Application (2021–2026)
Table 32. Global Drug-Device Combination Products Forecasted Market Size by Application (US$ Million), 2027–2032
Table 33. Global Drug-Device Combination Products Revenue Market Share by Application (2027–2032)
Table 34. North America Drug-Device Combination Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. North America Drug-Device Combination Products Market Size by Country (US$ Million), 2021–2026
Table 36. North America Drug-Device Combination Products Market Size by Country (US$ Million), 2027–2032
Table 37. Europe Drug-Device Combination Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 38. Europe Drug-Device Combination Products Market Size by Country (US$ Million), 2021–2026
Table 39. Europe Drug-Device Combination Products Market Size by Country (US$ Million), 2027–2032
Table 40. Asia-Pacific Drug-Device Combination Products Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 41. Asia-Pacific Drug-Device Combination Products Market Size by Region (US$ Million), 2021–2026
Table 42. Asia-Pacific Drug-Device Combination Products Market Size by Region (US$ Million), 2027–2032
Table 43. Latin America Drug-Device Combination Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Latin America Drug-Device Combination Products Market Size by Country (US$ Million), 2021–2026
Table 45. Latin America Drug-Device Combination Products Market Size by Country (US$ Million), 2027–2032
Table 46. Middle East & Africa Drug-Device Combination Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 47. Middle East & Africa Drug-Device Combination Products Market Size by Country (US$ Million), 2021–2026
Table 48. Middle East & Africa Drug-Device Combination Products Market Size by Country (US$ Million), 2027–2032
Table 49. GSK Company Details
Table 50. GSK Business Overview
Table 51. GSK Drug-Device Combination Products Product
Table 52. GSK Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 53. GSK Recent Development
Table 54. Novo Nordisk Company Details
Table 55. Novo Nordisk Business Overview
Table 56. Novo Nordisk Drug-Device Combination Products Product
Table 57. Novo Nordisk Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 58. Novo Nordisk Recent Development
Table 59. Eli Lilly Company Details
Table 60. Eli Lilly Business Overview
Table 61. Eli Lilly Drug-Device Combination Products Product
Table 62. Eli Lilly Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 63. Eli Lilly Recent Development
Table 64. AstraZeneca Company Details
Table 65. AstraZeneca Business Overview
Table 66. AstraZeneca Drug-Device Combination Products Product
Table 67. AstraZeneca Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 68. AstraZeneca Recent Development
Table 69. Sanofi Company Details
Table 70. Sanofi Business Overview
Table 71. Sanofi Drug-Device Combination Products Product
Table 72. Sanofi Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 73. Sanofi Recent Development
Table 74. Boston Scientific Company Details
Table 75. Boston Scientific Business Overview
Table 76. Boston Scientific Drug-Device Combination Products Product
Table 77. Boston Scientific Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 78. Boston Scientific Recent Development
Table 79. Abbott Company Details
Table 80. Abbott Business Overview
Table 81. Abbott Drug-Device Combination Products Product
Table 82. Abbott Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 83. Abbott Recent Development
Table 84. Boehringer Ingelheim Company Details
Table 85. Boehringer Ingelheim Business Overview
Table 86. Boehringer Ingelheim Drug-Device Combination Products Product
Table 87. Boehringer Ingelheim Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 88. Boehringer Ingelheim Recent Development
Table 89. Medtronic Company Details
Table 90. Medtronic Business Overview
Table 91. Medtronic Drug-Device Combination Products Product
Table 92. Medtronic Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 93. Medtronic Recent Development
Table 94. Viatris Company Details
Table 95. Viatris Business Overview
Table 96. Viatris Drug-Device Combination Products Product
Table 97. Viatris Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 98. Viatris Recent Development
Table 99. 3M Company Details
Table 100. 3M Business Overview
Table 101. 3M Drug-Device Combination Products Product
Table 102. 3M Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 103. 3M Recent Development
Table 104. Hisamitsu Company Details
Table 105. Hisamitsu Business Overview
Table 106. Hisamitsu Drug-Device Combination Products Product
Table 107. Hisamitsu Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 108. Hisamitsu Recent Development
Table 109. Smith & Nephew Company Details
Table 110. Smith & Nephew Business Overview
Table 111. Smith & Nephew Drug-Device Combination Products Product
Table 112. Smith & Nephew Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 113. Smith & Nephew Recent Development
Table 114. Molnlycke Company Details
Table 115. Molnlycke Business Overview
Table 116. Molnlycke Drug-Device Combination Products Product
Table 117. Molnlycke Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 118. Molnlycke Recent Development
Table 119. Teleflex Company Details
Table 120. Teleflex Business Overview
Table 121. Teleflex Drug-Device Combination Products Product
Table 122. Teleflex Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 123. Teleflex Recent Development
Table 124. BD Company Details
Table 125. BD Business Overview
Table 126. BD Drug-Device Combination Products Product
Table 127. BD Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 128. BD Recent Development
Table 129. Lepu Medical Company Details
Table 130. Lepu Medical Business Overview
Table 131. Lepu Medical Drug-Device Combination Products Product
Table 132. Lepu Medical Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 133. Lepu Medical Recent Development
Table 134. MicroPort Company Details
Table 135. MicroPort Business Overview
Table 136. MicroPort Drug-Device Combination Products Product
Table 137. MicroPort Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 138. MicroPort Recent Development
Table 139. Terumo Company Details
Table 140. Terumo Business Overview
Table 141. Terumo Drug-Device Combination Products Product
Table 142. Terumo Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 143. Terumo Recent Development
Table 144. B. Braun Company Details
Table 145. B. Braun Business Overview
Table 146. B. Braun Drug-Device Combination Products Product
Table 147. B. Braun Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 148. B. Braun Recent Development
Table 149. Antares Pharma Company Details
Table 150. Antares Pharma Business Overview
Table 151. Antares Pharma Drug-Device Combination Products Product
Table 152. Antares Pharma Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 153. Antares Pharma Recent Development
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
Table 157. Authors List of This Report
List of Figures
Figure 1. Drug-Device Combination Products Picture
Figure 2. Global Drug-Device Combination Products Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Drug-Device Combination Products Market Share by Type: 2025 vs 2032
Figure 4. Drug-Coated Device Features
Figure 5. Prefilled Drug Delivery Systems Features
Figure 6. Nebulizer and Inhaler Features
Figure 7. Transdermal Delivery System Features
Figure 8. Others Features
Figure 9. Global Drug-Device Combination Products Market Size by Application (US$ Million), 2021–2032
Figure 10. Global Drug-Device Combination Products Market Share by Application: 2025 vs 2032
Figure 11. Hospital andClinic Case Studies
Figure 12. Retail Pharmacies Case Studies
Figure 13. Other Case Studies
Figure 14. Drug-Device Combination Products Report Years Considered
Figure 15. Global Drug-Device Combination Products Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 16. Global Drug-Device Combination Products Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 17. Global Drug-Device Combination Products Market Share by Region: 2025 vs 2032
Figure 18. Global Drug-Device Combination Products Market Share by Players in 2025
Figure 19. Global Drug-Device Combination Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Drug-Device Combination Products Revenue in 2025
Figure 21. North America Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. North America Drug-Device Combination Products Market Share by Country (2021–2032)
Figure 23. United States Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Canada Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Europe Drug-Device Combination Products Market Share by Country (2021–2032)
Figure 27. Germany Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. France Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. U.K. Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Italy Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Russia Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Ireland Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Asia-Pacific Drug-Device Combination Products Market Share by Region (2021–2032)
Figure 35. China Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Japan Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. South Korea Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Southeast Asia Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. India Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Australia & New Zealand Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Latin America Drug-Device Combination Products Market Share by Country (2021–2032)
Figure 43. Mexico Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Brazil Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Middle East & Africa Drug-Device Combination Products Market Share by Country (2021–2032)
Figure 47. Israel Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Saudi Arabia Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. UAE Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. GSK Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 51. Novo Nordisk Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 52. Eli Lilly Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 53. AstraZeneca Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 54. Sanofi Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 55. Boston Scientific Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 56. Abbott Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 57. Boehringer Ingelheim Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 58. Medtronic Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 59. Viatris Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 60. 3M Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 61. Hisamitsu Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 62. Smith & Nephew Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 63. Molnlycke Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 64. Teleflex Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 65. BD Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 66. Lepu Medical Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 67. MicroPort Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 68. Terumo Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 69. B. Braun Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 70. Antares Pharma Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Table 1. Global Drug-Device Combination Products Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Drug-Coated Device
Table 3. Key Players of Prefilled Drug Delivery Systems
Table 4. Key Players of Nebulizer and Inhaler
Table 5. Key Players of Transdermal Delivery System
Table 6. Key Players of Others
Table 7. Global Drug-Device Combination Products Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Drug-Device Combination Products Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 9. Global Drug-Device Combination Products Market Size by Region (US$ Million), 2021–2026
Table 10. Global Drug-Device Combination Products Market Share by Region (2021–2026)
Table 11. Global Drug-Device Combination Products Forecasted Market Size by Region (US$ Million), 2027–2032
Table 12. Global Drug-Device Combination Products Market Share by Region (2027–2032)
Table 13. Drug-Device Combination Products Market Trends
Table 14. Drug-Device Combination Products Market Drivers
Table 15. Drug-Device Combination Products Market Challenges
Table 16. Drug-Device Combination Products Market Restraints
Table 17. Global Drug-Device Combination Products Revenue by Players (US$ Million), 2021–2026
Table 18. Global Drug-Device Combination Products Market Share by Players (2021–2026)
Table 19. Global Top Drug-Device Combination Products Players by Tier (Tier 1, Tier 2, and Tier 3), based on Drug-Device Combination Products Revenue, 2025
Table 20. Ranking of Global Top Drug-Device Combination Products Companies by Revenue (US$ Million) in 2025
Table 21. Global 5 Largest Players Market Share by Drug-Device Combination Products Revenue (CR5 and HHI), 2021–2026
Table 22. Global Key Players of Drug-Device Combination Products, Headquarters and Area Served
Table 23. Global Key Players of Drug-Device Combination Products, Products and Applications
Table 24. Global Key Players of Drug-Device Combination Products, Date of General Availability (GA)
Table 25. Mergers and Acquisitions, Expansion Plans
Table 26. Global Drug-Device Combination Products Market Size by Type (US$ Million), 2021–2026
Table 27. Global Drug-Device Combination Products Revenue Market Share by Type (2021–2026)
Table 28. Global Drug-Device Combination Products Forecasted Market Size by Type (US$ Million), 2027–2032
Table 29. Global Drug-Device Combination Products Revenue Market Share by Type (2027–2032)
Table 30. Global Drug-Device Combination Products Market Size by Application (US$ Million), 2021–2026
Table 31. Global Drug-Device Combination Products Revenue Market Share by Application (2021–2026)
Table 32. Global Drug-Device Combination Products Forecasted Market Size by Application (US$ Million), 2027–2032
Table 33. Global Drug-Device Combination Products Revenue Market Share by Application (2027–2032)
Table 34. North America Drug-Device Combination Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. North America Drug-Device Combination Products Market Size by Country (US$ Million), 2021–2026
Table 36. North America Drug-Device Combination Products Market Size by Country (US$ Million), 2027–2032
Table 37. Europe Drug-Device Combination Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 38. Europe Drug-Device Combination Products Market Size by Country (US$ Million), 2021–2026
Table 39. Europe Drug-Device Combination Products Market Size by Country (US$ Million), 2027–2032
Table 40. Asia-Pacific Drug-Device Combination Products Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 41. Asia-Pacific Drug-Device Combination Products Market Size by Region (US$ Million), 2021–2026
Table 42. Asia-Pacific Drug-Device Combination Products Market Size by Region (US$ Million), 2027–2032
Table 43. Latin America Drug-Device Combination Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Latin America Drug-Device Combination Products Market Size by Country (US$ Million), 2021–2026
Table 45. Latin America Drug-Device Combination Products Market Size by Country (US$ Million), 2027–2032
Table 46. Middle East & Africa Drug-Device Combination Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 47. Middle East & Africa Drug-Device Combination Products Market Size by Country (US$ Million), 2021–2026
Table 48. Middle East & Africa Drug-Device Combination Products Market Size by Country (US$ Million), 2027–2032
Table 49. GSK Company Details
Table 50. GSK Business Overview
Table 51. GSK Drug-Device Combination Products Product
Table 52. GSK Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 53. GSK Recent Development
Table 54. Novo Nordisk Company Details
Table 55. Novo Nordisk Business Overview
Table 56. Novo Nordisk Drug-Device Combination Products Product
Table 57. Novo Nordisk Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 58. Novo Nordisk Recent Development
Table 59. Eli Lilly Company Details
Table 60. Eli Lilly Business Overview
Table 61. Eli Lilly Drug-Device Combination Products Product
Table 62. Eli Lilly Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 63. Eli Lilly Recent Development
Table 64. AstraZeneca Company Details
Table 65. AstraZeneca Business Overview
Table 66. AstraZeneca Drug-Device Combination Products Product
Table 67. AstraZeneca Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 68. AstraZeneca Recent Development
Table 69. Sanofi Company Details
Table 70. Sanofi Business Overview
Table 71. Sanofi Drug-Device Combination Products Product
Table 72. Sanofi Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 73. Sanofi Recent Development
Table 74. Boston Scientific Company Details
Table 75. Boston Scientific Business Overview
Table 76. Boston Scientific Drug-Device Combination Products Product
Table 77. Boston Scientific Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 78. Boston Scientific Recent Development
Table 79. Abbott Company Details
Table 80. Abbott Business Overview
Table 81. Abbott Drug-Device Combination Products Product
Table 82. Abbott Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 83. Abbott Recent Development
Table 84. Boehringer Ingelheim Company Details
Table 85. Boehringer Ingelheim Business Overview
Table 86. Boehringer Ingelheim Drug-Device Combination Products Product
Table 87. Boehringer Ingelheim Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 88. Boehringer Ingelheim Recent Development
Table 89. Medtronic Company Details
Table 90. Medtronic Business Overview
Table 91. Medtronic Drug-Device Combination Products Product
Table 92. Medtronic Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 93. Medtronic Recent Development
Table 94. Viatris Company Details
Table 95. Viatris Business Overview
Table 96. Viatris Drug-Device Combination Products Product
Table 97. Viatris Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 98. Viatris Recent Development
Table 99. 3M Company Details
Table 100. 3M Business Overview
Table 101. 3M Drug-Device Combination Products Product
Table 102. 3M Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 103. 3M Recent Development
Table 104. Hisamitsu Company Details
Table 105. Hisamitsu Business Overview
Table 106. Hisamitsu Drug-Device Combination Products Product
Table 107. Hisamitsu Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 108. Hisamitsu Recent Development
Table 109. Smith & Nephew Company Details
Table 110. Smith & Nephew Business Overview
Table 111. Smith & Nephew Drug-Device Combination Products Product
Table 112. Smith & Nephew Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 113. Smith & Nephew Recent Development
Table 114. Molnlycke Company Details
Table 115. Molnlycke Business Overview
Table 116. Molnlycke Drug-Device Combination Products Product
Table 117. Molnlycke Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 118. Molnlycke Recent Development
Table 119. Teleflex Company Details
Table 120. Teleflex Business Overview
Table 121. Teleflex Drug-Device Combination Products Product
Table 122. Teleflex Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 123. Teleflex Recent Development
Table 124. BD Company Details
Table 125. BD Business Overview
Table 126. BD Drug-Device Combination Products Product
Table 127. BD Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 128. BD Recent Development
Table 129. Lepu Medical Company Details
Table 130. Lepu Medical Business Overview
Table 131. Lepu Medical Drug-Device Combination Products Product
Table 132. Lepu Medical Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 133. Lepu Medical Recent Development
Table 134. MicroPort Company Details
Table 135. MicroPort Business Overview
Table 136. MicroPort Drug-Device Combination Products Product
Table 137. MicroPort Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 138. MicroPort Recent Development
Table 139. Terumo Company Details
Table 140. Terumo Business Overview
Table 141. Terumo Drug-Device Combination Products Product
Table 142. Terumo Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 143. Terumo Recent Development
Table 144. B. Braun Company Details
Table 145. B. Braun Business Overview
Table 146. B. Braun Drug-Device Combination Products Product
Table 147. B. Braun Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 148. B. Braun Recent Development
Table 149. Antares Pharma Company Details
Table 150. Antares Pharma Business Overview
Table 151. Antares Pharma Drug-Device Combination Products Product
Table 152. Antares Pharma Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026
Table 153. Antares Pharma Recent Development
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
Table 157. Authors List of This Report
List of Figures
Figure 1. Drug-Device Combination Products Picture
Figure 2. Global Drug-Device Combination Products Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Drug-Device Combination Products Market Share by Type: 2025 vs 2032
Figure 4. Drug-Coated Device Features
Figure 5. Prefilled Drug Delivery Systems Features
Figure 6. Nebulizer and Inhaler Features
Figure 7. Transdermal Delivery System Features
Figure 8. Others Features
Figure 9. Global Drug-Device Combination Products Market Size by Application (US$ Million), 2021–2032
Figure 10. Global Drug-Device Combination Products Market Share by Application: 2025 vs 2032
Figure 11. Hospital andClinic Case Studies
Figure 12. Retail Pharmacies Case Studies
Figure 13. Other Case Studies
Figure 14. Drug-Device Combination Products Report Years Considered
Figure 15. Global Drug-Device Combination Products Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 16. Global Drug-Device Combination Products Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 17. Global Drug-Device Combination Products Market Share by Region: 2025 vs 2032
Figure 18. Global Drug-Device Combination Products Market Share by Players in 2025
Figure 19. Global Drug-Device Combination Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Drug-Device Combination Products Revenue in 2025
Figure 21. North America Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. North America Drug-Device Combination Products Market Share by Country (2021–2032)
Figure 23. United States Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Canada Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Europe Drug-Device Combination Products Market Share by Country (2021–2032)
Figure 27. Germany Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. France Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. U.K. Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Italy Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Russia Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Ireland Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Asia-Pacific Drug-Device Combination Products Market Share by Region (2021–2032)
Figure 35. China Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Japan Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. South Korea Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Southeast Asia Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. India Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Australia & New Zealand Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Latin America Drug-Device Combination Products Market Share by Country (2021–2032)
Figure 43. Mexico Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Brazil Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Middle East & Africa Drug-Device Combination Products Market Share by Country (2021–2032)
Figure 47. Israel Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Saudi Arabia Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. UAE Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. GSK Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 51. Novo Nordisk Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 52. Eli Lilly Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 53. AstraZeneca Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 54. Sanofi Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 55. Boston Scientific Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 56. Abbott Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 57. Boehringer Ingelheim Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 58. Medtronic Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 59. Viatris Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 60. 3M Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 61. Hisamitsu Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 62. Smith & Nephew Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 63. Molnlycke Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 64. Teleflex Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 65. BD Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 66. Lepu Medical Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 67. MicroPort Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 68. Terumo Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 69. B. Braun Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 70. Antares Pharma Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232